行情

JNJ

JNJ

强生
NYSE

实时行情|Nasdaq Last Sale

163.17
-1.19
-0.72%
盘后: 163.67 +0.5 +0.31% 19:58 09/27 EDT
开盘
164.00
昨收
164.36
最高
164.36
最低
162.85
成交量
577.55万
成交额
--
52周最高
179.92
52周最低
133.65
市值
4,295.42亿
市盈率(TTM)
24.53
分时
5日
1月
3月
1年
5年
简报-强生公司就 9 月 27 日在圣路易斯的辩护判决发表声明
reuters.com · 1小时前
强生股价周一下跌,跑输大市
Marketwatch.com · 5小时前
BRIEF-U.S. CDC Says Delivered 471,818,715 Doses Of Covid-19 Vaccine As Of Sept 27
reuters.com · 7小时前
无菌注射药物市场全球需求分析,2029 年机遇展望全球无菌注射药物市场概览
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
AmericaNewsHour · 9小时前
Acceleron Pharma 推动同行走高,而潜在的出售交易令投资者失望
Acceleron Pharma (XLRN +6.0%) looks set to continue its winning streak for the seventh consecutive session after Bloomberg reported that the biotech is considering a sale for more than $11 billion. The peers
Seekingalpha · 9小时前
直接作用抗病毒药物市场:2029 年全球需求分析和机会展望,其中详细概述了全球直接作用抗病毒药物市场
Research Nester released a report titled which delivers detailed overview of the global direct-acting antiviral medicines market in terms of market segmentation by drug class type, end-user and region.
AmericaNewsHour · 9小时前
拜登获得助推器;哈佛 MBA 上线:病毒更新
Bloomberg · 11小时前
现在购买的 10 只最佳德国股票
In this article, we discuss the 10 best German stocks to buy now. You can skip our detailed analysis of the best German stocks and go directly to read the 5 Best German Stocks to Buy Now. Germany is the biggest economy of Europe with 2020 gross domestic pr...
Insider Monkey · 12小时前
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解JNJ最新的财务预测,通过JNJ每股收益,每股净资产,每股现金流等数据分析强生近期的经营情况,然后做出明智的投资选择。
分析师评级

19位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测JNJ价格均价为188.88,最高价位215.00,最低价为160.00。
EPS
机构持股
总机构数: 4,008
机构持股: 19.25亿
持股比例: 73.12%
总股本: 26.32亿
类型机构数股数
增持
1,529
4,768.53万
建仓
111
860.53万
减持
1,256
3,813.60万
平仓
72
289.59万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
制药
-0.72%
制药与医学研究
-0.86%
高管信息
Chairman/Chief Executive Officer/Director
Alex Gorsky
Vice Chairman - Management/Chief Scientific Officer
Paulus Stoffels
Vice Chairman - Management
Joaquin Duato
Chief Financial Officer/Executive Vice President
Joseph Wolk
Chief Human Resource Officer/Executive Vice President
Peter Fasolo
Executive Vice President/General Counsel
Michael Ullmann
Executive Vice President
Ashley Mcevoy
Executive Vice President
Thibaut Mongon
Executive Vice President
Michael Sneed
Executive Vice President
Jennifer Taubert
Executive Vice President
Kathryn Wengel
Lead Director/Independent Director
Anne Mulcahy
Independent Director
Mary Beckerle
Independent Director
D. Scott Davis
Independent Director
Ian Davis
Independent Director
Jennifer Doudna
Independent Director
Marillyn Hewson
Independent Director
Hubert Joly
Independent Director
Mark Mcclellan
Independent Director
Charles Prince
Independent Director
A. Eugene Washington
Independent Director
Mark Weinberger
Independent Director
Nadja West
Independent Director
Ronald Williams
公告日期
每股分红
除权日期
2021/07/19
Dividend USD 1.06
2021/08/23
2021/04/20
Dividend USD 1.06
2021/05/24
2021/01/04
Dividend USD 1.01
2021/02/22
2020/10/22
Dividend USD 1.01
2020/11/23
2020/07/20
Dividend USD 1.01
2020/08/24
2020/04/14
Dividend USD 1.01
2020/05/22
2020/01/02
Dividend USD 0.95
2020/02/24
2019/10/17
Dividend USD 0.95
2019/11/25
2019/07/15
Dividend USD 0.95
2019/08/26
2019/04/25
Dividend USD 0.95
2019/05/24
2019/01/02
Dividend USD 0.9
2019/02/25
2018/10/18
Dividend USD 0.9
2018/11/26
2018/07/16
Dividend USD 0.9
2018/08/27
2018/04/26
Dividend USD 0.9
2018/05/25
2018/01/02
Dividend USD 0.84
2018/02/26
2017/10/19
Dividend USD 0.84
2017/11/27
2017/07/17
Dividend USD 0.84
2017/08/25
2017/04/27
Dividend USD 0.84
2017/05/25
2017/01/03
Dividend USD 0.8
2017/02/24
2016/10/21
Dividend USD 0.8
2016/11/18
JNJ 简况
强生公司是一家主要从事保健领域产品的研发、制造及销售业务的控股公司。该公司通过三个部门运营:消费品部门、医药部门及医疗器械部门。该公司主要重点关注与人类健康和福祉相关的产品。消费者部门包括一系列用于皮肤健康/美容、非处方药、婴儿护理、口腔护理、女性健康和伤口护理市场的产品。医药部门专注于六个部分,包括免疫学、传染病、神经科学、肿瘤学、心血管和代谢以及肺动脉高压。医疗器械部门包括一系列用于介入解决方案、骨科、外科和视觉领域的产品。

微牛提供Johnson & Johnson(NYSE-JNJ)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的JNJ股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易JNJ股票基本功能。